Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Efficacy and safety of the Chinese herbal medicine Xiao'er Niuhuang antipyretic plaster for treating fever in children with acute upper respiratory tract infection with wind-heat syndrome: a multicenter, randomized, double-blind, controlled clinical trial.

Created on 28 Jun 2026

Authors

Liu Na, Chen Zhimin, Zhao Gang, Yuan Bin, Huang Zhijun, Zhang Xuerong, Song Guihua, Chen Huafang

Published in

Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan. Volume 46. Issue 3. Pages 666-673.

Abstract

To evaluate the efficacy and safety of Xiao'er Niuhuang antipyretic plaster in treating fever associated with acute upper respiratory tract infection (AURI) accompanied by wind-heat syndrome in children.
A total of 464 pediatric patients diagnosed with AURI and wind-heat syndrome were enrolled. Participants were stratified into two age subgroups (1-2 years and 3-5 years) and then randomly assigned in a 3:1 ratio to receive either the Xiao'er Niuhuang antipyretic plaster or an extremely low-dose control plaster. The primary outcome was the time to onset of fever reduction. Safety assessments included monitoring of vital signs, laboratory tests (complete blood count, urinalysis, stool routine, and liver and kidney function), electrocardiogram, and local skin reactions.
The median time to onset of antipyretic effect was significantly shorter in the Xiao'er Niuhuang antipyretic plaster group than in the control group (2.53 h vs 3.98 h). The complete antipyretic rates at the 4-h time point were 31.76% for the Xiao'er Niuhuang antipyretic plaster group and 17.70% for the control group; at the 8-h time point, the rates were 49.55% and 33.04%, respectively. No significant difference was observed in the incidence of adverse events between the two groups (P >0.05). No serious adverse events were reported.
Xiao'er Niuhuang antipyretic plaster is an effective and safe treatment for fever in children with AURI and wind-heat syndrome.

PMID:
42365413
Bibliographic data and abstract were imported from PubMed on 28 Jun 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement